Ligand validation:6MVW

PX4: 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE

PX4 is a Ligand Of Interest in 6MVW designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6MVW_PX4_C_1301	28%	42%	0.293	0.951	1.16	1.08	3	2	3	0	100%	1
6MVW_PX4_B_2301	28%	37%	0.257	0.952	1.29	1.17	3	2	1	0	78%	0.7826
6MVW_PX4_A_1302	27%	29%	0.191	0.957	1.4	1.44	2	1	0	0	35%	0.3478
6MVW_PX4_C_1302	24%	43%	0.311	0.942	1.16	1.04	3	2	2	0	100%	1
6MVW_PX4_B_2303	22%	44%	0.281	0.958	1.07	1.08	2	1	6	0	67%	0.6739
6MVW_PX4_D_2302	19%	30%	0.255	0.936	1.54	1.24	3	3	0	0	52%	0.5217
6MVW_PX4_D_2301	17%	44%	0.317	0.958	1.08	1.09	2	1	2	0	67%	0.6739
6MVW_PX4_B_2302	11%	31%	0.276	0.889	1.44	1.31	3	2	1	0	48%	0.4783
6MVW_PX4_A_1303	9%	42%	0.383	0.918	1.11	1.14	2	2	0	0	80%	0.8043
6MVW_PX4_A_1301	8%	40%	0.35	0.898	1.27	1.09	3	1	1	0	59%	0.587
8DJ0_PX4_A_1301	65%	83%	0.148	0.949	0.31	0.46	-	-	2	0	100%	1
6MWD_PX4_B_2301	58%	44%	0.165	0.945	1.03	1.15	4	3	1	0	100%	1
6MWA_PX4_B_2301	55%	41%	0.149	0.944	1.09	1.21	4	4	4	0	85%	0.8478
8DJ1_PX4_A_1301	54%	89%	0.18	0.954	0.28	0.36	-	-	1	0	96%	0.9565
6MWG_PX4_B_2301	53%	42%	0.161	0.939	1.08	1.17	4	2	2	0	91%	0.913
8DIV_PX4_A_1302	50%	72%	0.182	0.934	0.4	0.69	-	3	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.